Update on Testosterone Replacement Therapy in Hypogonadal Men. (Q38528376)

3 September 2017

1 reference

title

Update on Testosterone Replacement Therapy in Hypogonadal Men. (English)

1 reference

3 September 2017

1 reference

Kevin Matthew Yen Bing Leung

series ordinal

1

1 reference

3 September 2017

Khalid Alrabeeah

series ordinal

2

1 reference

3 September 2017

Serge Carrier

series ordinal

3

1 reference

3 September 2017

1 August 2015

1 reference

3 September 2017

Current urology reports

1 reference

3 September 2017

16

1 reference

3 September 2017

8

1 reference

3 September 2017

57

1 reference

https://scigraph.springernature.com/pub.10.1007/s11934-015-0523-9

3 September 2017

0 references

cites work

Update in testosterone therapy for men.

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

21 January 2018

Testosterone deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Evaluation of assays available to measure free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Accuracy of calculated free testosterone formulae in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Diagnosis and treatment of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Is testosterone treatment good for the prostate? Study of safety during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone supplementation does not worsen lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Metabolic syndrome, testosterone, and cardiovascular mortality in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Beneficial and adverse effects of testosterone on the cardiovascular system in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone concentrations in diabetic and nondiabetic obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Inverse association between total testosterone concentrations, incident hypertension and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone and metabolic syndrome: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Elevated high sensitivity C-reactive protein levels in aging men with low testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone, cardiovascular disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Prostate cancer risk in testosterone-treated men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone and prostate cancer: revisiting old paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Serum testosterone level, testosterone replacement treatment, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone replacement therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Insulin resistance, body fat distribution, and sex hormones in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Cardiometabolic risks during anabolic hormone supplementation in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Risks and benefits of testosterone therapy in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Testosterone and depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0523-9

Relationship of sex hormones to lipids and lipoproteins in nondiabetic men

21 January 2018

1 reference

12 December 2020

A ten-year safety study of the oral androgen testosterone undecanoate.

1 reference

12 December 2020

Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort

1 reference

12 December 2020

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

1 reference

12 December 2020

Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy

1 reference

12 December 2020

Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)

1 reference

12 December 2020

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

12 December 2020

Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men

1 reference

12 December 2020

Hypogonadism and metabolic syndrome

1 reference

12 December 2020

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

12 December 2020

Low testosterone levels are associated with coronary artery disease in male patients with angina

1 reference

12 December 2020

Testosterone therapy in men with untreated prostate cancer

1 reference

12 December 2020

The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).

1 reference

12 December 2020

Low testosterone levels are associated with carotid atherosclerosis in men

1 reference

12 December 2020

10.1007/S11934-015-0523-9

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference